价格

Prednisolone/Prednisone

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

NOVEL ANTITUMORAL USE OF CABAZITAXEL
- US 20240139146 A1
  申请人: SANOFI MATURE IP优先权: 2009
  CN
  US
  7 件公开
- CN 104784187 A
  申请人: AVENTIS PHARMA SA优先权: 2009
  CN
  2 件公开
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
US 8821873 B2申请人: BIOGEN IDEC INC优先权: 2013
US
5 件公开
NIRAPARIB AND ABIRATERONE ACETATE PLUS PREDNISONE TO IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND HRR ALTERATIONS
EP 4472634 A1申请人: JANSSEN PHARMACEUTICA NV优先权: 2022
EP
US
WO
3 件公开
Hapten, immunogens and derivatives of ascomycin useful for preparation of antibodies and immunoassays
US 2005176080 A1申请人: BODEPUDI VANI优先权: 2005
US
2 件公开
Cabazitaxel and its use for treating metastatic prostate cancers
CN 105073104 A申请人: AVENTIS PHARMA SA优先权: 2013
CN
2 件公开
Hormone target chemotherapy medicine for lymph using C as carrier, and use thereof
CN 1404879 A申请人: SHANGHAI ATOMIC NUCLUS INST CH优先权: 2002
CN
Anti-cancer medicine composition carried with platinum-like compounds and glucocorticoid hormone
CN 101023918 A申请人: KONGQUAN MEDICINE SCIENCE TECH优先权: 2006
CN
Entity-tumor-resistant slow-release agent
CN 101023919 A申请人: KANGQUAN MEDICINE SCIENCE TECH优先权: 2006
CN
PREPARATION FOR THE TREATMENT OF EQUINE LAMINITIS
US 2010190805 A1申请人: BOEHRINGER INGELHEIM VETMED优先权: 2007
US
Medicine composition containing oral glucocorticoid and oral bronchodilator
CN 101797258 A申请人: MO SHIPING优先权: 2009
CN

药物

Prednisolone/Prednisone

专利

NOVEL ANTITUMORAL USE OF CABAZITAXEL